Atopic dermatitis
Conditions
Sponsors
Shiba Palace Clinic
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1)Japanese females aged from 20 to 50 years old at the time informed consent was provided 2)Patients with mild to moderate atopic dermatitis 3)Patients who provided written informed consent to change from their everyday use of cleanser or facial sunscreen to the test agent during the study period
Exclusion criteria
Exclusion criteria: ?Patients with severe or greater atopic dermatitis ?Patients receiving systemic administration of a drug for a purpose other than atopic dermatitis therapy ?Patients receiving a topically administered drug on the face for a purpose other than atopic dermatitis therapy ?Pregnant women, those who may be pregnant, lactating women, or women who hope to become pregnant during the study period ?Patients for whom the test agent is contraindicated ?Patients who were considered inappropriate for the study by an investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of dermatological assessment and questionnaire before and after the repeated use of cleansing foam or facial sunscreen for 1 and 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood test, measurement of transepidermal water loss (TEWL) and skin moisture | — |
Countries
Japan
Contacts
Public ContactMiwa Kaneko
SOUKEN Co.,Ltd Clinical trial division
Outcome results
None listed